rubidium has been researched along with hydralazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisker, RV; Horsman, MR; Overgaard, J | 1 |
| Adragna, NC; Lauf, PK; Orlov, SN; White, RE | 1 |
2 other study(ies) available for rubidium and hydralazine
| Article | Year |
|---|---|
Hydralazine-induced changes in tissue perfusion and radiation response in a C3H mammary carcinoma and mouse normal tissues.
Topics: Animals; Cell Hypoxia; Chlorides; Female; Hydralazine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Perfusion; Radiotherapy Dosage; Rubidium; Tissue Distribution | 1991 |
K-Cl cotransport in vascular smooth muscle and erythrocytes: possible implication in vasodilation.
Topics: Alkaloids; Animals; Aorta; Biological Transport; Carbazoles; Carrier Proteins; Cells, Cultured; Chlorides; Coronary Vessels; Enzyme Inhibitors; Erythrocytes; Ethylmaleimide; Genistein; Hydralazine; Indoles; Isometric Contraction; Isosorbide Dinitrate; K Cl- Cotransporters; Marine Toxins; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Oxazoles; Potassium; Propylene Glycols; Rats; Rubidium; Sheep; Swine; Symporters; Vasoconstriction; Vasodilation; Vasodilator Agents | 2000 |